These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15531760)

  • 1. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase.
    Tintignac LA; Lagirand J; Batonnet S; Sirri V; Leibovitch MP; Leibovitch SA
    J Biol Chem; 2005 Jan; 280(4):2847-56. PubMed ID: 15531760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.
    Lagirand-Cantaloube J; Cornille K; Csibi A; Batonnet-Pichon S; Leibovitch MP; Leibovitch SA
    PLoS One; 2009; 4(3):e4973. PubMed ID: 19319192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase.
    Jogo M; Shiraishi S; Tamura TA
    FEBS Lett; 2009 Sep; 583(17):2715-9. PubMed ID: 19631210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase kinase 1 (MEK1) stabilizes MyoD through direct phosphorylation at tyrosine 156 during myogenic differentiation.
    Jo C; Cho SJ; Jo SA
    J Biol Chem; 2011 May; 286(21):18903-13. PubMed ID: 21454680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region.
    Hsu JM; Lee YC; Yu CT; Huang CY
    J Biol Chem; 2004 Jul; 279(31):32592-602. PubMed ID: 15145941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of essential sequences for cellular localization in the muscle-specific ubiquitin E3 ligase MAFbx/Atrogin 1.
    Julie LC; Sabrina BP; Marie-Pierre L; Leibovitch SA
    FEBS Lett; 2012 Feb; 586(4):362-7. PubMed ID: 22249105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 ubiquitin ligase SCF
    Chen F; Zhang C; Wu H; Ma Y; Luo X; Gong X; Jiang F; Gui Y; Zhang H; Lu F
    J Biol Chem; 2017 Dec; 292(49):20100-20112. PubMed ID: 29070679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice.
    Cong H; Sun L; Liu C; Tien P
    Hum Gene Ther; 2011 Mar; 22(3):313-24. PubMed ID: 21126200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells.
    Li JJ; Zhang TP; Meng Y; Du J; Li HH
    Cell Physiol Biochem; 2011; 27(5):463-70. PubMed ID: 21691063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXO25, an F-box protein homologue of atrogin-1, is not induced in atrophying muscle.
    Maragno AL; Baqui MM; Gomes MD
    Biochim Biophys Acta; 2006 Jun; 1760(6):966-72. PubMed ID: 16714087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
    Li HH; Kedar V; Zhang C; McDonough H; Arya R; Wang DZ; Patterson C
    J Clin Invest; 2004 Oct; 114(8):1058-71. PubMed ID: 15489953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role for lysine 133 in the nuclear ubiquitin-mediated degradation of MyoD.
    Batonnet S; Leibovitch MP; Tintignac L; Leibovitch SA
    J Biol Chem; 2004 Feb; 279(7):5413-20. PubMed ID: 14660660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase Skp1-cullin-F-box ligase (SCF) interact through multiple conformations.
    Sandoval D; Hill S; Ziemba A; Lewis S; Kuhlman B; Kleiger G
    J Biol Chem; 2015 Jan; 290(2):1106-18. PubMed ID: 25425648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
    Chen G; Wang Y; Garate M; Zhou J; Li G
    Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise.
    Okada A; Ono Y; Nagatomi R; Kishimoto KN; Itoi E
    Muscle Nerve; 2008 Oct; 38(4):1246-53. PubMed ID: 18785187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting.
    Lokireddy S; Wijesoma IW; Sze SK; McFarlane C; Kambadur R; Sharma M
    Am J Physiol Cell Physiol; 2012 Sep; 303(5):C512-29. PubMed ID: 22673621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD.
    Trausch-Azar JS; Lingbeck J; Ciechanover A; Schwartz AL
    J Biol Chem; 2004 Jul; 279(31):32614-9. PubMed ID: 15163661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and Id1 during muscle differentiation.
    Sun L; Trausch-Azar JS; Ciechanover A; Schwartz AL
    J Biol Chem; 2005 Jul; 280(28):26448-56. PubMed ID: 15888449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
    Lagirand-Cantaloube J; Offner N; Csibi A; Leibovitch MP; Batonnet-Pichon S; Tintignac LA; Segura CT; Leibovitch SA
    EMBO J; 2008 Apr; 27(8):1266-76. PubMed ID: 18354498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.